## Abstract Eight ovarian cancer patients with ascites resistant to various chemotherapy protocols were treated i.p. with __C. parvum__ in an effort to obtain a palliative reduction of peritoneal effusions. __C. parvum__(7β14 mg) was given i.p. on days 0, 7, 28 and then at monthly intervals. Three
β¦ LIBER β¦
Effect of i.p. C. Parvum on the tumoricidal activity of tumor-associated macrophages and tumor-associated lymphocytes from ascitic ovarian tumors
β Scribed by M. Introna; C. Sessa; G. Peri; P. Allavena; N. Polentarutti; C. Mangioni; A. Mantovani
- Book ID
- 107927306
- Publisher
- Elsevier Science
- Year
- 1982
- Tongue
- English
- Weight
- 71 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Intraperitoneal administration of coryne
β
Alberto Mantovani; Cristiana Sessa; Giuseppe Peri; Paola Allavena; Martino Intro
π
Article
π
1981
π
John Wiley and Sons
π
French
β 921 KB
Effects of the immunopotentiators C. par
β
D. Gemsa; E. BΓ€rlin; H.G. Leser; G. Till; K. Resch
π
Article
π
1980
π
Elsevier Science
π
English
β 166 KB
Anticancer activity of zoanthids and the
β
R. J. Quinn; Midori Kashiwagi; Richard E. Moore; Ted R. Norton
π
Article
π
1974
π
John Wiley and Sons
π
English
β 382 KB
Effect of cisplatin and FK565 on the act
β
Prahlad Parajuli; Sukh Mahendra Singh; Ashok Kumar
π
Article
π
1995
π
Elsevier Science
π
English
β 525 KB
The effect of the interferon-Ξ³-inducible
β
Ulrike Kuckelkorn; EditeβAntunes Ferreira; Ilse Drung; Ulrike Liewer; Peter-Mich
π
Article
π
2002
π
John Wiley and Sons
π
English
β 168 KB
π 1 views
The human wild-type (wt) p53.264-272 peptide is a universal tumor antigen and recognized by HLA-A\*0201 (A2.1)-restricted CTL. Generation of this epitope by constitutive 20S proteasomes is prevented by a p53 R to H hotspot mutation at the C-terminal flanking residue 273. We report on the impact of t